Certified by Founder
Lodge
hema.to GmbH
start up
Germany
- Munich
- 07/03/2025
- Unknown
- $3,900,060
We are a deeptech AI company obsessed with solving cytometry and thereby make an outsized and lasting impact on immune medicine: we want to make sure every patient gets the right treatment at the right time for their unique immune systems.
- Industry Software Development
- Website https://www.hema.to/
- LinkedIn https://www.linkedin.com/company/hemato/
Related People
Karsten MiermansFounder
Germany -
Munich, Bavaria
Founder of an AI diagnostic start-up, passionate about improving cytometry and blood cancer diagnostics. I have a background in theoretical biophysics, but I'm a generalist at heart. My fundamental drivers are growth, honesty, efficiency and curiosity. In my spare time, I enjoy reading great works, electronic music and teaching rationality.
SpeedLabs | $6,500,000 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
XCENA | $135,000,000 | (Jun 2, 2026)
Gray Swan | $40,000,000 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
Countable Labs | $26,000,000 | (May 29, 2026)
Rep AI | $6,200,000 | (May 29, 2026)
Psilera | $8,800,000 | (May 29, 2026)
Reactor | $59,000,000 | (May 29, 2026)
MokN | $15,000,000 | (May 29, 2026)
Crimson | $2,500,000 | (May 29, 2026)
Orebella | Undisclosed Amount | (May 29, 2026)